#35 Private Company 🇨🇦 Canada

Canurta Therapeutics

BTC Holdings

3

BTC NAV
$216,609.2
Avg Cost / BTC
$101,619
Total Cost Basis
$286,071.12
Holdings BTC vs USD value
₿3
$217K USD value · as of May 19, 2026
BTC Holdings (left)
USD Value (right)
BitcoinTreasuries logo

Historical Holdings

About Canurta Therapeutics

Canurta Therapeutics is a Canadian biotech company advancing botanical therapeutics for inflammatory and neurodegenerative diseases. Through its proprietary PolyKye™ Platform, Canurta combines AI-powered discovery, blockchain-secured supply chains, and globally patented compounds to deliver novel treatments for conditions like ALS and Alzheimer’s. Its lead candidate, CNR-401, is progressing toward Phase 2/3 trials. Canurta holds Bitcoin on its balance sheet as part of its long-term capital strategy, aiming to build a sustainable treasury through its innovative Satoshi Trials™ initiative.

Bitcoin Treasury Intelligence

Stay ahead of institutional Bitcoin accumulation.

Every week: new treasury entrants, mNAV movements, Digital Credit updates, and the data that matters to serious Bitcoin investors.

No spam. Unsubscribe anytime. Read by institutional analysts worldwide.